Blood and Immunity Practice Questions

Q: Which of the following is required for iron absorption, synthesized in the liver, and transported to the intestine via bile secretion?

Apotransferrin. ### Explanation **Correct Answer: B. Apotransferrin** The absorption of iron in the small intestine involves a specific mechanism involving **Apotransferrin**. The liver synthesizes apotransferrin and secretes it into the **bile**, which then carries it to the duodenum and jejunum. In the intestinal lumen, apotransferrin binds with free iron (forming **Transferrin**) or hemoglobin/myoglobin iron. This complex then binds to specific receptors on the brush border of intestinal epithelial cells and is internalized via endocytosis. Inside the cell, the iron is released into the blood, and the apotransferrin is recycled back to the lumen to pick up more iron. **Analysis of Incorrect Options:** * **A. Apoferritin:** This is the protein shell that stores iron *inside* cells (primarily in the liver and intestinal mucosa). When iron binds to apoferritin, it becomes **Ferritin**. It is not secreted in bile for absorption. * **C. Transferrin:** While apotransferrin becomes transferrin once it binds iron, the question specifically asks for the substance *synthesized and secreted* by the liver to facilitate the process. Furthermore, plasma transferrin (the transport form in blood) is distinct from the biliary apotransferrin involved in the initial luminal uptake. **High-Yield NEET-PG Pearls:** * **Site of Absorption:** Iron is primarily absorbed in the **duodenum** and upper jejunum. * **Hepcidin:** The "Master Regulator" of iron metabolism. It is a liver-derived peptide that inhibits iron release by binding to and degrading **Ferroportin** (the basal outlet for iron). * **Vitamin C:** Enhances iron absorption by reducing ferric iron ($Fe^{3+}$) to the more soluble ferrous form ($Fe^{2+}$). * **DMT-1 (Divalent Metal Transporter 1):** The primary transporter for non-heme iron across the apical membrane of enterocytes.

Q: Which of the following is NOT a known function of platelet-activating factor (PAF)?

Congestive heart failure. **Explanation:** Platelet-activating factor (PAF) is a potent phospholipid-derived mediator produced by various cells, including platelets, neutrophils, monocytes, and endothelial cells. It acts via G-protein-coupled receptors to trigger diverse physiological and pathological processes. **Why Option D is Correct:** **Congestive Heart Failure (CHF)** is primarily a hemodynamic and structural disorder of the heart. While PAF has potent cardiovascular effects—such as inducing systemic hypotension and reducing myocardial contractility (negative inotropy)—it is **not** a known causative factor or a primary mediator in the pathogenesis of CHF. Therefore, it is the "except" in this list. **Why the other options are incorrect:** * **Option A (Ovulation):** PAF plays a crucial role in reproductive physiology. It is involved in the rupture of the mature Graafian follicle by stimulating the release of proteolytic enzymes and prostaglandins necessary for ovulation. * **Option B (Hemostasis and Thrombosis):** As the name suggests, PAF is one of the most potent stimulators of platelet aggregation and degranulation. It plays a central role in thrombus formation and the inflammatory response of the vascular endothelium. * **Option C (Bronchial Asthma):** PAF is a key mediator in Type I hypersensitivity. It causes potent bronchoconstriction (300–1000 times more potent than histamine) and increases vascular permeability, leading to airway edema and mucus secretion. **High-Yield Clinical Pearls for NEET-PG:** * **Source:** PAF is synthesized from membrane phospholipids by the enzyme **Phospholipase A2**. * **Potency:** It is one of the most potent known chemotactic agents for neutrophils and eosinophils. * **Anaphylaxis:** PAF is a major mediator in the pathogenesis of anaphylactic shock. * **Antagonist:** **Ginkgolide B** (derived from the Ginkgo biloba tree) is a specific PAF receptor antagonist often mentioned in pharmacology.

Q: Which of the following statements regarding blood coagulation is true?

Platelets are essential for blood clot formation.. ### Explanation **Correct Option: D. Platelets are essential for blood clot formation.** Platelets (thrombocytes) play a dual role in hemostasis. Initially, they form a **primary platelet plug** (primary hemostasis). Subsequently, they provide a phospholipid surface (**Platelet Factor 3**) essential for the activation of the coagulation cascade, which leads to the formation of a stable fibrin mesh (secondary hemostasis). Without platelets, the conversion of prothrombin to thrombin is severely impaired, and clots cannot retract. **Analysis of Incorrect Options:** * **Option A:** Vitamin K is a fat-soluble vitamin required for the **gamma-carboxylation** of factors II, VII, IX, and X in the **liver**. It has no direct effect on blood that has already been drawn (in vitro) because the clotting factors are already synthesized. * **Option B:** The process is the reverse. **Thrombin** (Factor IIa) acts as a proteolytic enzyme that converts the soluble plasma protein **fibrinogen** into insoluble **fibrin** monomers. * **Option C:** Heparin acts by activating **Antithrombin III**, which then inactivates Thrombin and Factor Xa. It is **Warfarin (Coumadin)** that inhibits blood coagulation by interfering with Vitamin K metabolism (inhibiting Vitamin K epoxide reductase). **High-Yield Clinical Pearls for NEET-PG:** * **Vitamin K Dependent Factors:** II, VII, IX, X, Protein C, and Protein S ("1972"). * **Clot Retraction:** This process depends on the contractile protein **thrombosthenin** found in platelets. * **Calcium (Factor IV):** It is required for almost every step of the coagulation cascade except the first two steps of the intrinsic pathway. This is why EDTA/Citrate (calcium chelators) are used as anticoagulants in blood vials. * **Bleeding Time (BT)** assesses platelet function, while **Prothrombin Time (PT)** and **aPTT** assess the coagulation cascade.

Q: Haemostasis depends upon all the following, EXCEPT?

Vitamin B. **Explanation:** Haemostasis is the physiological process that stops bleeding at the site of vascular injury. It involves a complex interplay between the vessel wall, platelets, and coagulation factors. **Why Vitamin B is the correct answer:** Vitamin B (specifically the B-complex group) is primarily involved in energy metabolism, red blood cell synthesis (B12 and Folate), and neurological function. It does **not** play a direct role in the coagulation cascade or the formation of a fibrin clot. Therefore, haemostasis does not depend on Vitamin B. **Analysis of other options:** * **Calcium (Factor IV):** It is essential for almost all steps of the coagulation cascade (except the initial stages of the intrinsic pathway). It acts as a bridge between phospholipids and clotting factors. * **Prothrombin (Factor II):** This is a plasma protein produced by the liver. It is converted into **thrombin**, the key enzyme that transforms soluble fibrinogen into insoluble fibrin strands to form a stable clot. * **Vitamin K:** This is a vital fat-soluble vitamin required for the post-translational gamma-carboxylation of **Factors II, VII, IX, and X**, as well as Protein C and S. Without Vitamin K, these factors are synthesized but remain biologically inactive. **High-Yield Clinical Pearls for NEET-PG:** * **Vitamin K Antagonist:** Warfarin acts by inhibiting Vitamin K epoxide reductase, preventing the activation of Clotting Factors II, VII, IX, and X. * **Chelating Agents:** Substances like EDTA and Citrate prevent blood clotting in vitro by binding to **Calcium**, making it unavailable for the coagulation cascade. * **Vitamin B12/Folate Deficiency:** Leads to Megaloblastic Anemia, not bleeding disorders. However, severe deficiency can cause pancytopenia, which may lead to thrombocytopenia (low platelets) and subsequent bleeding.

Q: Blood groups A1 and A2 differ in?

Chemical structure of antigen. **Explanation:** The differentiation between blood groups **A1 and A2** is a classic high-yield topic in Immunohematology. While both belong to the ABO system, they differ qualitatively and quantitatively. **1. Why "Chemical structure of antigen" is correct:** The primary difference lies in the **complexity of the carbohydrate chains**. Both A1 and A2 individuals possess the A-transferase enzyme, which adds N-acetylgalactosamine (GalNAc) to the H-substance. However, the **A1 enzyme** is more efficient and can convert both simple and branched precursor chains (Type 1, 2, 3, and 4) into A-antigens. In contrast, the **A2 enzyme** is less efficient and primarily acts on simple, linear chains. This results in a distinct **chemical structure** and a significantly higher density of A-antigen sites on A1 cells (approx. 1 million) compared to A2 cells (approx. 250,000). **2. Why other options are incorrect:** * **Spatial configuration:** This refers to the 3D folding of proteins. Since A-antigens are carbohydrates (glycosphingolipids/glycoproteins), the core difference is the chemical linkage and branching, not just a spatial rearrangement. * **Molecular groups:** While they have different numbers of antigenic sites, the term "molecular groups" is too vague and does not specifically describe the biochemical basis of blood group specificity. * **Ionic charges:** Surface charge (Zeta potential) is primarily determined by sialic acid on the RBC membrane and does not define the specificity of A1 vs. A2 subtypes. **Clinical Pearls for NEET-PG:** * **Anti-A1 Antibody:** About 1–8% of A2 individuals and 25% of A2B individuals produce naturally occurring Anti-A1. This can cause **ABO discrepancy** during cross-matching. * **Lectins:** *Dolichos biflorus* is the lectin used to identify A1 cells (it agglutinates A1 but not A2). * **A1 vs. A2:** A1 is the most common subtype (80%), while A2 is the second most common (20%).

Q: The extrinsic pathway of clotting is activated by?

Release of tissue thromboplastin. **Explanation:** The coagulation cascade is divided into the intrinsic and extrinsic pathways, which converge into a common pathway. **Why Option A is Correct:** The **extrinsic pathway** is the body’s rapid response to tissue injury. It is initiated when damaged extravascular tissues release **Tissue Factor (TF)**, also known as **Tissue Thromboplastin (Factor III)**. Once released, Factor III binds with Factor VII in the presence of calcium to form a complex that directly activates Factor X, marking the start of the common pathway. It is called "extrinsic" because the initiating factor (TF) is external to the blood. **Why Other Options are Incorrect:** * **B & C:** The formation of prothrombin and the conversion of fibrinogen to fibrin are steps in the **Common Pathway**. These occur *after* the extrinsic or intrinsic pathways have already been activated. * **D:** Calcium (Factor IV) is a necessary cofactor for almost all steps of the clotting cascade (except the first two steps of the intrinsic pathway), but it is not the *initiator* of the extrinsic pathway. **NEET-PG High-Yield Pearls:** * **Speed:** The extrinsic pathway is much faster than the intrinsic pathway, occurring in seconds. * **Monitoring:** The extrinsic pathway is clinically monitored using **Prothrombin Time (PT)**. * **Key Factor:** Factor VII has the shortest half-life of all clotting factors; therefore, PT is the first to be prolonged in liver disease or Vitamin K deficiency. * **Mnemonic:** "The **Ex**-boyfriend (Extrinsic) is **PT** (Petty) and lives **Outside** (Tissue Factor)."

Q: Red cell volume can be measured by injecting tagged red blood cells. All of the following are used to tag red cells, EXCEPT:

121I. To measure **Red Cell Volume (RCV)**, the principle of **indicator dilution** is used. This requires a tracer that binds specifically and firmly to erythrocytes. ### Why 121I is the Correct Answer **121I (Radioactive Iodine)** is not used to tag red blood cells. Iodine isotopes (specifically **125I** and **131I**) are used to label **Serum Albumin**. Therefore, radio-iodinated albumin is the gold standard for measuring **Plasma Volume**, not red cell volume. Using an iodine tracer for RCV would yield inaccurate results as it remains in the extracellular fluid/plasma compartment. ### Explanation of Incorrect Options (Used for RCV) * **51Cr (Radioactive Chromium):** This is the **most common** and standard method for measuring RCV. It binds to the beta chain of hemoglobin. * **32P (Radioactive Phosphorus):** This was historically used to label RBCs by incorporating into the cell membrane/metabolism, though it is less common now than 51Cr. * **59Fe (Radioactive Iron):** Iron is a core component of heme. It can be used to tag RBCs, though it is more frequently used in studies of erythropoiesis and iron kinetics. ### Clinical Pearls for NEET-PG * **Total Blood Volume:** Measured using **51Cr-labeled RBCs** (most accurate) or calculated as *Plasma Volume / (1 - Hematocrit)*. * **Plasma Volume tracers:** 125I-Albumin, 131I-Albumin, and **Evans Blue dye** (T-1824). * **Extracellular Fluid (ECF) tracers:** Inulin (Gold standard), Mannitol, Sucrose, and isotopes of Na+, Cl-, or Br-. * **Total Body Water tracers:** Deuterium Oxide ($D_2O$), Tritium Oxide ($T_2O$), and Aminopyrine.

Q: How do platelets aid in clot stabilization?

Release of calcium. **Explanation:** Platelets play a pivotal role in the coagulation cascade beyond just forming a primary plug. The correct answer is **Release of calcium** because calcium (Factor IV) is an essential cofactor for almost every step of the clotting cascade. 1. **Why Calcium is Correct:** Platelets contain **dense granules** (delta granules) that store and release high concentrations of ionized calcium. Calcium acts as a "bridge" between clotting factors and the phospholipid surface of activated platelets. It is specifically required for the activation of Factor X and the conversion of prothrombin to thrombin. Without calcium, the secondary hemostasis process cannot stabilize the initial platelet plug into a firm fibrin clot. 2. **Why Other Options are Incorrect:** * **Factor VIII:** This is primarily synthesized in the liver and endothelial cells (associated with von Willebrand factor), not released by platelets. * **Thrombomodulin:** This is an endothelial cell receptor that binds thrombin to activate Protein C (an anticoagulant). It inhibits clotting rather than stabilizing it. * **Thrombasthenin:** While platelets do contain this contractile protein, its role is in **clot retraction** (shrinking the clot) rather than the biochemical stabilization of the fibrin meshwork itself. **High-Yield NEET-PG Pearls:** * **Platelet Granules:** Remember the mnemonic **"SAC"** for Dense granules: **S**erotonin, **A**DP/ATP, and **C**alcium. * **Alpha Granules:** Contain vWF, Fibrinogen, and Platelet-Derived Growth Factor (PDGF). * **Chelating Agents:** Citrate and EDTA prevent blood clotting in vitro by sequestering calcium ions. * **Glanzmann Thrombasthenia:** A deficiency of GpIIb/IIIa, leading to defective platelet aggregation.

Question 1

Which of the following is required for iron absorption, synthesized in the liver, and transported to the intestine via bile secretion?

Accepted Answer

Apotransferrin

Answer

Apoferritin

Answer

Transferrin

Answer

All of the above

Question 2

Which of the following is NOT a known function of platelet-activating factor (PAF)?

Accepted Answer

Congestive heart failure

Answer

Rupture of mature graafian follicle and ovulation

Answer

Hemostasis and thrombosis

Answer

Bronchial asthma

Question 3

Which of the following statements regarding blood coagulation is true?

Accepted Answer

Platelets are essential for blood clot formation.

Answer

Addition of Vitamin K to a freshly drawn blood sample delays clotting.

Answer

Thrombin converts fibrin to fibrinogen.

Answer

Heparin inhibits blood coagulation by interfering with Vitamin K metabolism in the liver.

Question 4

Which of the following changes does NOT occur in blood passing through the systemic capillaries?

Accepted Answer

Shift of the oxygen-hemoglobin dissociation curve to the left

Answer

Increase in hematocrit

Answer

Decrease in pH

Answer

Increase in protein concentration

Question 5

Haemostasis depends upon all the following, EXCEPT?

Accepted Answer

Vitamin B

Answer

Calcium

Answer

Prothrombin

Answer

Vitamin K

Question 6

Blood groups A1 and A2 differ in?

Accepted Answer

Chemical structure of antigen

Answer

Spatial configuration of antigen

Answer

Molecular groups

Answer

Ionic charges on surface

Question 7

The extrinsic pathway of clotting is activated by?

Accepted Answer

Release of tissue thromboplastin

Answer

Conversion of fibrinogen into fibrin

Answer

Formation of prothrombin

Answer

Release of calcium

Question 8

Red cell volume can be measured by injecting tagged red blood cells. All of the following are used to tag red cells, EXCEPT:

Accepted Answer

121I

Answer

51Cr

Answer

59Fe

Answer

32P

Question 9

Progenitor hematopoietic stem cells originate in which of the following?

Accepted Answer

Bone marrow

Answer

Thymus

Answer

Lymph node

Answer

Spleen

Question 10

How do platelets aid in clot stabilization?

Accepted Answer

Release of calcium

Answer

Release of factor 8

Answer

Release of thrombomodulin

Answer

Activation of thrombasthenin

Blood and Immunity — MCQs

Blood and Immunity — MCQs

On this page

Practice by Chapter

Want unlimited practice?